|
25
Sep
2018
Ascendis launches new strategic focus, announces positive FY18 results By: Features Deputy Editor ECONOMY JSE-listed pharmaceutical company Ascendis Health on Tuesday announced a new strategic focus prioritising pharmaceutical and consumer healthcare. The company, which also reported on its results for the financial year ended June 30, plans to divest its biosciences businesses.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access
|
Hydrogen 2024: Implementation crucial going forward
Buy Report
Roads, Rail & Ports 2024: Inefficiencies reach new lows
Buy Report
Africa Mining Projects in Progress 2024
Buy Report
Iron-Ore 2023/24: Bracing for change
Buy Report
Platinum Group Metals 2023: Crucial Element in the Energy Transition
Buy Report
Automotive 2023: Navigating change
Buy Report
